Sarah Province and Martha Hustek, filed on March 21, 2016.; The Petitioner is seeking the Board’s interpretation of Rule 64B3-10.005, F.A.C., in two situations. First, can a cytotechnologist process, perform pretesting and testing procedures and ...

 

DEPARTMENT OF HEALTH

Board of Clinical Laboratory Personnel

RULE NO.:RULE TITLE:

64B3-10.005Scope of Practice Relative to Specialty of Licensure

NOTICE IS HEREBY GIVEN that the Board of Clinical Laboratory Personnel has received the petition for declaratory statement from Sarah Province and Martha Hustek, filed on March 21, 2016. The petition seeks the agency’s opinion as to the applicability of Rule 64B3-10.005, Florida Administrative Code, as it applies to the petitioner.

The Petitioner is seeking the Board’s interpretation of Rule 64B3-10.005, F.A.C., in two situations. First, can a cytotechnologist process, perform pretesting and testing procedures and interpret clinical laboratory test results for the Vysis UroVysion Bladder Cancer Kit and whether a Florida licensed clinical laboratory technician, technologist, supervisor, or director collect, process, perform pretesting procedures, perform testing procedures, and interpret clinical laboratory test results for any test utilizing Fluorescence in situ hybridization (FISH) method regardless of test FDA categorization. Except for good cause shown, motions for leave to intervene must be filed within 21 days after the publication of this notice.

A copy of the Petition for Declaratory Statement may be obtained by contacting: Anthony B. Spivey, Executive Director, Board of Clinical Laboratory Personnel, 4052 Bald Cypress Way, Bin C07, Tallahassee, Florida 32399-3257or by email at [e-mail] within 14 days of publication of this notice.